CN1870995A - 使用埃坡霉素的癌症治疗 - Google Patents
使用埃坡霉素的癌症治疗 Download PDFInfo
- Publication number
- CN1870995A CN1870995A CNA2004800313316A CN200480031331A CN1870995A CN 1870995 A CN1870995 A CN 1870995A CN A2004800313316 A CNA2004800313316 A CN A2004800313316A CN 200480031331 A CN200480031331 A CN 200480031331A CN 1870995 A CN1870995 A CN 1870995A
- Authority
- CN
- China
- Prior art keywords
- purposes
- treatment
- proliferative disease
- epothilones
- tumor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49954803P | 2003-09-02 | 2003-09-02 | |
| US60/499,548 | 2003-09-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1870995A true CN1870995A (zh) | 2006-11-29 |
Family
ID=34272839
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2004800313316A Pending CN1870995A (zh) | 2003-09-02 | 2004-09-01 | 使用埃坡霉素的癌症治疗 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20060235059A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1663214A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2007504259A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1870995A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2004268377B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0414043A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2537057A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA06002393A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2005020989A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1640004A1 (en) * | 2004-09-24 | 2006-03-29 | Schering Aktiengesellschaft | Use of epothilones in the treatment of bone metastases and bone tumors or cancers |
| CN100384419C (zh) * | 2005-12-02 | 2008-04-30 | 菏泽睿鹰制药集团有限公司 | 一种埃坡霉素缓释植入组合物及应用 |
| WO2010005726A2 (en) | 2008-06-16 | 2010-01-14 | Bind Biosciences Inc. | Therapeutic polymeric nanoparticles with mtor inhibitors and methods of making and using same |
| AU2009268923B2 (en) | 2008-06-16 | 2015-09-17 | Pfizer Inc. | Drug loaded polymeric nanoparticles and methods of making and using same |
| EA020753B1 (ru) | 2008-06-16 | 2015-01-30 | Бинд Терапьютикс, Инк. | Терапевтические полимерные наночастицы, содержащие алкалоиды vinca, и их применение |
| WO2010068866A2 (en) | 2008-12-12 | 2010-06-17 | Bind Biosciences | Therapeutic particles suitable for parenteral administration and methods of making and using same |
| EA201100765A1 (ru) | 2008-12-15 | 2012-04-30 | Бинд Биосаиэнсис | Наночастицы длительной циркуляции для замедленного высвобождения терапевтических средств |
| CN102811743B (zh) | 2009-12-11 | 2015-11-25 | 佰恩德治疗股份有限公司 | 冻干治疗颗粒的稳定制剂 |
| JP5965844B2 (ja) | 2009-12-15 | 2016-08-10 | バインド セラピューティックス インコーポレイテッド | 高いガラス転移温度または高分子量のコポリマーを有する治療用ポリマーナノ粒子組成物 |
| EP2512459A4 (en) * | 2009-12-15 | 2013-08-07 | THERAPEUTIC POLYMERIC NANOPARTICLES COMPRISING EPOTHILONE AND METHODS OF MAKING AND USING SAME | |
| HUE043998T2 (hu) | 2012-09-17 | 2019-09-30 | Pfizer | Eljárás terápiás nanorészecskék elõállítására |
| EP3116547B1 (en) | 2014-03-14 | 2019-06-05 | Pfizer Inc | Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4820269A (en) * | 1983-03-07 | 1989-04-11 | Vanderbilt University | Mixer apparatus for controlling intravenous drug infusion |
| US5968972A (en) * | 1995-10-26 | 1999-10-19 | Baker Norton Pharmaceuticals, Inc. | Method for increasing the oral bioactivity of pharmaceutical agents |
| US6302838B1 (en) * | 1998-02-25 | 2001-10-16 | Novartis Ag | Cancer treatment with epothilones |
| FR2775187B1 (fr) * | 1998-02-25 | 2003-02-21 | Novartis Ag | Utilisation de l'epothilone b pour la fabrication d'une preparation pharmaceutique antiproliferative et d'une composition comprenant l'epothilone b comme agent antiproliferatif in vivo |
| DE60225666T2 (de) * | 2001-01-25 | 2009-04-16 | Bristol-Myers Squibb Co. | Verfahren zur herstellung von pharmazeutischen zusammensetzungen enthaltend epothilon-analoga zur krebsbehandlung |
| ATE554756T1 (de) * | 2001-03-14 | 2012-05-15 | Bristol Myers Squibb Co | Kombination aus epothilon-analog und chemotherapeutika zur behandlung von proliferativen erkrankungen |
| TWI287986B (en) * | 2001-12-13 | 2007-10-11 | Novartis Ag | Use of Epothilones for the treatment of the carcinoid syndrome |
| AU2003235761A1 (en) * | 2002-01-14 | 2003-07-24 | Novartis Ag | Combinations comprising epothilones and anti-metabolites |
| CN1649585A (zh) * | 2002-05-01 | 2005-08-03 | 诺瓦提斯公司 | 用于治疗肝脏肿瘤和其它癌症疾病的埃坡霉素衍生物 |
| AU2003296878A1 (en) * | 2002-05-20 | 2004-12-13 | Kosan Biosciences, Inc. | Methods to administer epothilone d |
| ES2297189T3 (es) * | 2002-08-02 | 2008-05-01 | Novartis Ag | Derivados de epotilona. |
| CA2510610A1 (en) * | 2002-12-09 | 2004-06-24 | Novartis Ag | Microtubule stabilisers for treating stenosis in stents |
| EP1641449A1 (en) * | 2003-06-27 | 2006-04-05 | Novartis AG | Cancer treatment with epothilones |
-
2004
- 2004-09-01 CN CNA2004800313316A patent/CN1870995A/zh active Pending
- 2004-09-01 CA CA002537057A patent/CA2537057A1/en not_active Abandoned
- 2004-09-01 AU AU2004268377A patent/AU2004268377B2/en not_active Ceased
- 2004-09-01 BR BRPI0414043-5A patent/BRPI0414043A/pt not_active IP Right Cessation
- 2004-09-01 US US10/570,850 patent/US20060235059A1/en not_active Abandoned
- 2004-09-01 EP EP04764699A patent/EP1663214A1/en not_active Ceased
- 2004-09-01 MX MXPA06002393A patent/MXPA06002393A/es not_active Application Discontinuation
- 2004-09-01 JP JP2006525704A patent/JP2007504259A/ja active Pending
- 2004-09-01 WO PCT/EP2004/009737 patent/WO2005020989A1/en not_active Ceased
-
2008
- 2008-11-12 US US12/269,293 patent/US20090069394A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20060235059A1 (en) | 2006-10-19 |
| US20090069394A1 (en) | 2009-03-12 |
| CA2537057A1 (en) | 2005-03-10 |
| BRPI0414043A (pt) | 2006-10-24 |
| AU2004268377B2 (en) | 2008-06-26 |
| MXPA06002393A (es) | 2006-06-20 |
| EP1663214A1 (en) | 2006-06-07 |
| JP2007504259A (ja) | 2007-03-01 |
| WO2005020989A1 (en) | 2005-03-10 |
| AU2004268377A1 (en) | 2005-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7875601B2 (en) | Cancer treatment with epothilones | |
| US6302838B1 (en) | Cancer treatment with epothilones | |
| US20090069394A1 (en) | Cancer treatment with epothilones | |
| CN104507479B (zh) | 通过联合治疗的半胱天冬酶‑3酶原激活 | |
| CN1679559A (zh) | 癌症的治疗 | |
| CN101065127A (zh) | 包含埃博霉素和蛋白酪氨酸激酶抑制剂的组合产品及其药物用途 | |
| CN1547471A (zh) | 含有combretastatin和抗癌剂的复合药物 | |
| CN1361693A (zh) | 1,4-苯并硫氮杂∴衍生物作为抗癌药抗性克服用药物的用途 | |
| CN1649585A (zh) | 用于治疗肝脏肿瘤和其它癌症疾病的埃坡霉素衍生物 | |
| CN1575168A (zh) | 包含选择性环加氧酶-2抑制剂的组合 | |
| CN1233178A (zh) | 用于治疗性功能障碍的吡唑啉酮类 | |
| CN1675219A (zh) | 喜树碱和不饱和脂肪酸的新的抗癌共轭体 | |
| CN101065129B (zh) | 治疗癌症的n-(3-甲氧基-5-甲基吡嗪-2-基)-2-(4-[1,3,4-噁二唑-2-基]苯基)吡啶-3-磺酰胺和抗有丝分裂剂的组合 | |
| JP2009513486A (ja) | エポチロンでの癌処置 | |
| RU2242229C2 (ru) | Применение эпотилонов для лечения рака | |
| AU2003202508B2 (en) | Use of epothilones for the treatment of cancer | |
| CN1299773C (zh) | 一种抗癌药物组合物 | |
| CN1694691A (zh) | 用蒽环类和紫杉烷类治疗转移性乳癌 | |
| CN1204962A (zh) | 含2,2'-二-1h-吡咯化合物的协同免疫抑制组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Open date: 20061129 |